3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 4
1
Phase 3
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
28
Prostatic Neoplasms
14
Neoplasm Metastasis
12
Osteoporosis
8
Multiple Myeloma
8
Pain
7
Lung Neoplasms
4
Fractures, Bone
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasms, Plasma Cell
3
Humoral Hypercalcemia Of Malignancy
3
Bone Neoplasms
3
Bone Diseases, Metabolic
3
Spinal Cord Compression
2
Neoplasms
2
Lymphoma
2
Hematologic Neoplasms
2
Triple Negative Breast Neoplasms
1
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Paraproteinemias
1
Osteosarcoma
1
Neoplastic Processes
1
Lymphoma, Non-Hodgkin
1
Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
1
Hematologic Diseases
1
Giant Cell Tumor of Bone
1
Disease Progression
1
Interventions
Sunitinib
20
Nivolumab
16
cabozantinib
12
Sorafenib
12
pembrolizumab
11
pazopanib
9
Ipilimumab
9
Interferon-alpha
9
belzutifan
8
Everolimus
8
lenvatinib
7
Bevacizumab
7
aldesleukin
6
Magnetic Resonance Spectroscopy
6
Axitinib
6
atezolizumab
5
Interferon alpha-2
4
temsirolimus
3
Specimen Handling
3
Radiosurgery
3
Nephrectomy
3
Interleukin-2
3
tivozanib
2
durvalumab
2
avelumab
2
Saline Solution
2
G250 monoclonal antibody
2
Fluorouracil
2
Chemotherapy, Adjuvant
2
CTLA-4 Antigen
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Renal Cell
×
Zoledronic Acid
×
Clear all
NCT03408652
2021-10-22
MOSCAR
Centre Leon Berard
Phase 3
Terminated
1 enrolled